1 janv. 1987 - KR. Brav introduccs CA-549 as a serum tumor marker primarily for breast cancer; S, Fukuta introduces CA-195 as a
serum tumor marker primarily for colorectal cancer by this date at least 1,215 expressed genes are assigned to specific
chromosomes
